Loading...
Derniers dépôts
![Chargement de la page](/img/loading.gif)
Nombre de notices
1 213
Nombre de documents
1 126
Répartition par type de documents
Evolution
Dernières publications
-
Christine Durier, Laetitia Ninove, Sylvie van der Werf, Maeva Lefebvre, Corinne Desaint, et al.. Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination. Infectious Diseases Now, 2024, 54 (5), pp.104886. ⟨10.1016/j.idnow.2024.104886⟩. ⟨hal-04596145⟩
-
Daniela Ogonczyk-Makowska, Pauline Brun, Clémence Vacher, Caroline Chupin, Clément Droillard, et al.. Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice. NPJ vaccines, 2024, 9 (1), pp.111. ⟨10.1038/s41541-024-00899-9⟩. ⟨hal-04633271⟩
-
Marta Nunes, Edward Thommes, Holger Fröhlich, Antoine Flahault, Julien Arino, et al.. Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report. Infectious Disease Modelling, 2024, 9 (2), pp.501-518. ⟨10.1016/j.idm.2024.02.008⟩. ⟨hal-04551033⟩
-
Paul Loubet, Jean-Daniel Lelievre, Alexis Francois, Elisabeth Botelho-Nevers, Christian Chidiac, et al.. Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: a French nationwide multicenter cohort study - ANRS0001s COV-POPART. International Journal of Infectious Diseases, 2024, 146, pp.107110. ⟨10.1016/j.ijid.2024.107110⟩. ⟨hal-04627501⟩
-
-
-
Stanislas Thiriet-Rupert, Jérôme Josse, David Perez-Pascual, Jason Tasse, Camille Andre, et al.. Analysis of in-patient evolution of Escherichia coli reveals potential links to relapse of bone and joint infections. Journal of Infectious Diseases, 2024, 229 (5), pp.1546-1556. ⟨10.1093/infdis/jiad528⟩. ⟨pasteur-04297206⟩
-
-
-